157 related articles for article (PubMed ID: 23498063)
1. Androgen-deprivation therapy and cardiovascular harm: let's not throw out the baby with the bathwater.
Nguyen PL
Eur Urol; 2014 Apr; 65(4):710-2. PubMed ID: 23498063
[No Abstract] [Full Text] [Related]
2. Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.
Schooling CM; Sembajwe G; Agalliu I
Eur Urol; 2013 Sep; 64(3):e59-60. PubMed ID: 23623050
[No Abstract] [Full Text] [Related]
3. Reply to C. Mary Schooling, Grace Sembajwe and Ilir Agalliu's letter to the editor Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.
Jespersen CG; Nørgaard M; Borre M
Eur Urol; 2013 Sep; 64(3):e61. PubMed ID: 23622775
[No Abstract] [Full Text] [Related]
4. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.
Jespersen CG; Nørgaard M; Borre M
Eur Urol; 2014 Apr; 65(4):704-9. PubMed ID: 23433805
[TBL] [Abstract][Full Text] [Related]
5. Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.
Goonewardene SS; Persad R; Young A; Makar A
Eur Urol; 2014 Sep; 66(3):e51-2. PubMed ID: 24813269
[No Abstract] [Full Text] [Related]
6. Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort Study.
Chen DY; See LC; Liu JR; Chuang CK; Pang ST; Hsieh IC; Wen MS; Chen TH; Lin YC; Liaw CC; Hsu CL; Chang JW; Kuo CF; Huang WK
J Clin Oncol; 2017 Nov; 35(32):3697-3705. PubMed ID: 28968166
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?
Zhang K; Zhang L; Hao Z; Liang C
World J Urol; 2016 Jun; 34(6):879-81. PubMed ID: 26424563
[No Abstract] [Full Text] [Related]
8. Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer.
Teoh JY; Chan SY; Chiu PK; Poon DM; Cheung HY; Hou SS; Ng CF
Asian J Androl; 2015; 17(3):493-6. PubMed ID: 25578930
[TBL] [Abstract][Full Text] [Related]
9. Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review.
Meng F; Zhu S; Zhao J; Vados L; Wang L; Zhao Y; Zhao D; Niu Y
BMC Cancer; 2016 Mar; 16():180. PubMed ID: 26940836
[TBL] [Abstract][Full Text] [Related]
10. Toward personalizing the use of androgen deprivation therapy to maximize benefit and minimize harm.
Nguyen PL; D'Amico AV
Eur Urol; 2015 Sep; 68(3):397-8. PubMed ID: 25542627
[No Abstract] [Full Text] [Related]
11. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
Keating NL; O'Malley A; Freedland SJ; Smith MR
J Natl Cancer Inst; 2012 Oct; 104(19):1518-23. PubMed ID: 23210129
[No Abstract] [Full Text] [Related]
12. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
[TBL] [Abstract][Full Text] [Related]
13. Weighing up the risks and benefits of androgen deprivation therapy.
Rees J
Practitioner; 2014 May; 258(1771):5. PubMed ID: 25055405
[No Abstract] [Full Text] [Related]
14. Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Liu R; Zhou J; Xia S; Li T
Urol Int; 2020; 104(3-4):214-221. PubMed ID: 31747673
[TBL] [Abstract][Full Text] [Related]
15. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer.
Azoulay L; Yin H; Benayoun S; Renoux C; Boivin JF; Suissa S
Eur Urol; 2011 Dec; 60(6):1244-50. PubMed ID: 21908097
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
Keating NL; O'Malley AJ; Smith MR
J Clin Oncol; 2006 Sep; 24(27):4448-56. PubMed ID: 16983113
[TBL] [Abstract][Full Text] [Related]
17. Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogue.
Soloway MS
Urology; 2002 Nov; 60(5):735-7. PubMed ID: 12429286
[No Abstract] [Full Text] [Related]
18. Metabolic syndrome and prostate cancer: a review.
Nobes JP; Langley SE; Laing RW
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):183-91. PubMed ID: 19111451
[TBL] [Abstract][Full Text] [Related]
19. Does the benefit justify the risk?
Albertsen PC
J Natl Cancer Inst; 2010 Jan; 102(1):4-5. PubMed ID: 19996059
[No Abstract] [Full Text] [Related]
20. [Cardiovascular risks of androgen deprivation therapy for prostate cancer].
Miller K
Urologe A; 2016 May; 55(5):627-31. PubMed ID: 27003571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
